Sort
48,018 grants matching “immunotherapy”
TRANSFORMING TRIPLE-NEGATIVE BREAST CANCER TREATMENT THROUGH INTRATUMORAL IMMUNOTHERAPY VIA NANOFLUIDIC DRUG-ELUTING SEED
$834,791The Methodist Hospital Research Institute · · FY2020 · Defense Health Agency
The cross-talk between a-Synucleinopathies and T cell immunity in ADRD
$834,685Xiaobo Mao · Johns Hopkins University · R01 · FY2024 · AG
Monoclonal antibody isolation and characterization
$834,675Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Heterogeneity of T cell phenotype and function in food allergy
$834,664Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AI
Heterogeneity of T cell phenotype and function in food allergy
$834,664Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AI
Theranostic CAR-T Targeting Senescence in Alzheimer's
$834,627Lina Cui · University Of Florida · R61 · FY2025 · AG
Immunologic correlates of functional cure of HBV with immune checkpoint blockade
$834,534Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2022 · AI
Immunologic correlates of functional cure of HBV with immune checkpoint blockade
$834,534Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2021 · AI
Immunologic correlates of functional cure of HBV with immune checkpoint blockade
$834,534Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2023 · AI
Immunologic correlates of functional cure of HBV with immune checkpoint blockade
$834,534Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2024 · AI
Novel Biologic Therapies for BMT: Mechanistic Evaluation in Rhesus Macaques
$834,441Leslie S Kean · Emory University · R01 · FY2010 · HL
Development of Novel Approaches to Optimize CAR T-cell Therapies for B-cell Malignancies
$834,260Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Vaccine and Drug Combination Therapy for Human Cancers
$833,695James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Vaccine and radiation for the therapy of human cancers
$833,695James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Combination Therapy with Semaglutide and Anti-Amyloid Antibodies for Alzheimers Disease
$833,674Cynthia A Lemere · Brigham And Women'S Hospital · R01 · FY2025 · AG
Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
$833,492Javid J Moslehi · Vanderbilt University Medical Center · R01 · FY2021 · HL
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$833,369Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2018 · CA
ENHANCING RENAL CELL CARCINOMA IMMUNOTHERAPY WITH NEOEPITOPE VACCINATION STRATEGIES
$833,345The Research Foundation For The State University Of New York · · FY2022 · Defense Health Agency
Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes
$833,334Wei-Chiao Huang · Pop Biotechnologies, Inc · R42 · FY2025 · AG
EPITOPE BASED DNA VACCINES FOR AIDS THERAPY
$833,081Idm Pharma, Inc. · P01 · FY2000 · AI
Anti-sphingolipid antibodies for the treatment of cancer
$832,672Lpath Therapeutics, Inc. · R44 · FY2005 · CA
Immunologic Correlates of Immunization for Cancer
$832,603University Of Washington · U54 · FY2005 · CA
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
$832,516Harriet M Kluger · Yale University · K12 · FY2021 · CA
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
$832,061Justin M Balko · Vanderbilt University Medical Center · R01 · FY2021 · HL
TOLERANCE TO ISLET ALLOGRAFTS IN TYPE I DIABETES
$831,774University Of Minnesota Twin Cities · R01 · FY2005 · DK